
Necrotizing pneumonia is a severe and potentially life-threatening complication of a lung infection in which parts of the lung tissue start to die. Although the estimated incidence is rare at less than 1% in adults, those numbers may be underreported, said Tracy T. Ashby, DO, FCCP, who emphasized that clinicians will encounter the condition in their practice. And when they do, they must navigate a lack of clear diagnostic criteria and standardized management strategies.
Dr. Ashby, pulmonary and critical care specialist and Associate Professor of Medicine at the University of Florida Health, will chair the CHEST 2026 session Contemporary Challenges in Necrotizing Pneumonia: A Case-Based Discussion at 8 am MST on Tuesday, October 20, in the Phoenix Convention Center, West Building, Room 106C.
“Through our case-based panel discussion, session attendees will learn how necrotizing pneumonia arises when a pulmonary infection triggers severe inflammation, leading to parenchymal damage, tissue necrosis, and the liquefaction of consolidated lung tissue,” Dr. Ashby said. “We will also provide a comprehensive review of the current literature on this condition, as well as innovative approaches to the management of necrotizing pneumonia and the effectiveness of interventional therapies.”
In addition to information on the key interventions used in the management of necrotizing pneumonia, including pleural drainage, diagnostic and therapeutic bronchoscopy, and surgery, the session will also include a review of recently published data on the role and clinical indication for the use of extracorporeal membrane oxygenation (ECMO) as a bridge to recovery in patients with severe disease, Dr. Ashby said. In this clinical indication, ECMO allows native lung tissue time to heal while attenuating the effects of ventilator-induced lung injury.
Rather than four individual case-based presentations, a panel of four experts will provide an integrated approach on caring for patients with necrotizing pneumonia.
“We will go over diagnosis through one of the first cases and then discuss medical management in the second patient case, including the use of antibiotics, as well as other interventional strategies clinicians can consider. And through the last case, we’ll talk about the potential role of more invasive management approaches, including the use of extracorporeal membrane oxygenation as a bridge to recovery, as well as the role of surgery,” Dr. Ashby said.
In addition to Dr. Ashby, the panel will include George Rakovich, MD, MA, Chief of Thoracic Surgery at Maisonneuve-Rosemont Hospital; Leela Krishna Teja Boppana, MD, MBBS, a critical care pulmonologist at Samaritan Health; and Sebastian Kurz, MD, PhD, FCCP, Associate Professor at Yale University and Clinical Director of the COPD Program at the Yale Center for Asthma and Airway Disease.
“Attendees will learn from the perspective of top clinicians in this field,” Dr. Ashby said, “and they’ll leave with a best practices approach for diagnosing and managing patients with necrotizing pneumonia.”

Call for Topics Is Open
Feeling inspired by all the great sessions you’ve attended? Help shape the curriculum for CHEST 2027, October 24 to 27 in Vancouver, by submitting topic ideas from areas you’re passionate about, topics affecting your practice, or new technologies you’d like to learn more about. The submission deadline is Tuesday, December 1, at 2 pm CT.



